Home > Healthcare > Pharmaceuticals > Drug Delivery > Inhalable Drugs Market

Inhalable Drugs Market Share

Report ID: GMI10744
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Inhalable Drugs Market Share

The inhalable drugs sector is competitive in nature, with a mix of major global and smaller to medium-sized companies competing for market share. A pivotal aspect of market strategy involves the continual introduction of innovative products leveraging diverse technologies. Notably, prominent industry players command considerable influence in this dynamic landscape, often driving forward advancements through substantial investments in research and development. Additionally, strategic alliances, acquisitions, and mergers are instrumental in fortifying market positions and expanding global footprint amidst evolving regulatory landscapes.

Inhalable Drugs Market Companies

Some of the eminent market participants operating in the inhalable drugs industry include:

AstraZeneca Plc
C.H. Boehringer Sohn AG & Co. KG.
CHIESI Farmaceutici S.p.A.
Cipla Limited
GSK plc
MannKind Corporation
Merck & Co., Inc.
Mundipharma International.
Novartis AG
Pfizer Inc.
PULMATRIX, INC.
Philip Morris International Inc.
Sanofi
Teva Pharmaceutical Industries Ltd.
Viatris,Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global inhalable drugs industry was valued at USD 33.4 billion in 2023 and is anticipated to register 6.8% CAGR between 2024 and 2032 due to the increasing prevalence of respiratory diseases and advancements in inhalation technology.

The respiratory diseases segment in the market recorded USD 24.2 billion in 2023 due to targeted lung delivery, rapid onset, and improving efficacy.

U.S. inhalable drugs market is projected to reach USD 21.8 billion by 2032 due to increasing pharmaceutical and biotechnological innovation and rising investment in R&D.

AstraZeneca Plc, C.H. Boehringer Sohn AG & Co. KG., CHIESI Farmaceutici S.p.A., Cipla Limited, GSK plc, MannKind Corporation, Merck & Co., Inc., Mundipharma International., Novartis AG, and Pfizer Inc., among others.